openPR Logo
Press release

Global Cardiac Point-of-Care (POCs) Market to Witness Stellar Growth Rate in the Next 10 Years

01-04-2019 05:14 AM CET | Health & Medicine

Press release from: Persistence Market Research

Global Cardiac Point-of-Care (POCs) Market to Witness Stellar

Cardiac POC is a medical test performed to diagnose patients. The cardiac POCs are blood tests including cholesterol and coagulation testing. These include brain natriuretic peptide tests and troponin. Troponin are used to analyse various cardiovascular conditions such as coronary syndromes, heart failures and acute myocardial. The cardiac POCs help in enzyme detection which is released during critical cardiac conditions such as troponin, lactate, dehydrogenase isoenzymes and brain natriuretic peptides. In addition, it also helps in detection of enzymes released during failure of the heart. Cardiac POCs are helpful in diagnosing specific diseases such as myocardial infarction and angina. Cardiac POCs provides accurate information related to the markers which are released during heart failure. These tests help in reducing turnaround time from testing to final results of the patient’s diagnosis. Thus, helps in providing effective treatment to the patients.

Request Sample Report@ www.persistencemarketresearch.com/samples/3215

North America is dominating cardiac POCs market followed by Europe due to rising demand of home healthcare. In addition, increasing number of cardiac patients in these regions is also driving the cardiac POC market growth. Asia Pacific region is expected to grow at a moderate rate attributable to rising healthcare expenditures and increasing awareness for diagnosis treatment.

Some of the drivers for the growth of the global cardiac POCs market are increasing number of cardiac patients and demand of immediate diagnosis of the diseases. In addition lower turnaround time for results and availability of technologically advanced products with various features such as miniaturization and automation are also boosting the growth of the cardiac POC market. However, economic slowdown and reimbursements issues are restraining the cardiac POC market growth.

Request TOC@ www.persistencemarketresearch.com/methodology/3215

Lack of specific actions in detecting the presence of cardiovascular diseases emerges as one of the market challenges for the growth of global cardiac POC market. On the other hand, new product launches, mergers and acquisitions and partnerships are some recent trend in the global cardiac POC market. In addition, growing number of decentralized diagnostics facilities are another emerging market trend for global cardiac POC market. Some of the key market players operating in global cardiac POC market are Abbott Laboratories, Alere Inc., Roche Diagnostics, Boston Scientific Corp and Medtronic Inc.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cardiac Point-of-Care (POCs) Market to Witness Stellar Growth Rate in the Next 10 Years here

News-ID: 1469828 • Views:

More Releases from Persistence Market Research

Peptones Market to Reach US$ 512.5 Million by 2032 at 4.6% CAGR | Persistence Market Research
Peptones Market to Reach US$ 512.5 Million by 2032 at 4.6% CAGR | Persistence Ma …
The global peptones market size is valued at US$ 373.7 million in 2025 and is projected to reach US$ 512.5 million by 2032, growing at a CAGR of 4.6% between 2025 and 2032. Market growth is largely supported by expanding biotechnology research activities and increasing pharmaceutical production capabilities. Animal-based peptones remain among the leading product categories due to their extensive use in microbial cultivation. Geographically, North America leads the market
CMO/CDMO Biotechnology Market to Reach US$168.9 Billion by 2032 at 12.5% CAGR | Persistence Market Research
CMO/CDMO Biotechnology Market to Reach US$168.9 Billion by 2032 at 12.5% CAGR | …
The global CMO/CDMO biotechnology market size is likely to be valued at US$74.0 Billion in 2025 and is estimated to reach US$168.9 Billion by 2032, expanding at a CAGR of 12.5% during 2025-2032. The market is supported by increased investments in bioprocessing technologies, rising clinical trial activities, and growing demand for advanced therapeutic products. Biologics manufacturing services remain the leading segment due to increasing monoclonal antibody production. North America dominates
Medical Wellness Market to Reach US$3.7 Billion by 2032 at 10.6% CAGR | Persistence Market Research
Medical Wellness Market to Reach US$3.7 Billion by 2032 at 10.6% CAGR | Persiste …
The global medical wellness market size is expected to reach US$1.8 billion by 2025. It is estimated to reach US$3.7 billion by 2032, growing at a CAGR of 10.6% during the forecast period from 2025 to 2032. Increasing health consciousness, growing corporate wellness adoption, digital health integration, and demand for integrated healthcare experiences are supporting market growth. Wellness centers offering preventive screening, nutrition planning, stress management, and personalized care are
Acne Treatment Market to Reach US$ 11,825.1 Mn by 2032 at 6.1% CAGR | Persistence Market Research
Acne Treatment Market to Reach US$ 11,825.1 Mn by 2032 at 6.1% CAGR | Persistenc …
The global market for acne treatment is estimated to value at US$ 11,825.1 Mn by the end of 2032 from US$ 7,812.6 Mn recorded in 2025. The market is expected to secure a CAGR of 6.1% in the forthcoming years from 2025 to 2032. Growing incidences of hormonal disorders, increasing urbanization, changing dietary patterns, and rising stress levels are contributing to acne prevalence worldwide. Topical medications continue to represent a

All 5 Releases


More Releases for POC

Primary Catalyst Driving POC Medical Imaging Market Evolution in 2025: Chronic D …
What market dynamics are playing a key role in accelerating the growth of the poc medical imaging market? The escalating occurrence of long-term diseases is predicted to boost the expansion of the point-of-care medical imaging market in the future. The chronic disease prevalence pertains to the fraction or the count of people in a community affected by enduring health ailments at any given moment. This transition originates from lifestyle options, inherited
Transforming the Point-of-Care (POC) Coagulation Testing Market in 2025: Cardiov …
"What Is the Expected Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market? The point-of-care (POC) coagulation testing market has grown significantly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025, at a CAGR of 5.8%. The growth is driven by increasing patient demand, the growing trend of point-of-care testing, high reliability in coagulation status testing, automation, integration with electronic health records
POC Diagnostic Testing Devices | 1drop
1drop Inc.'s POC diagnostic testing devices are essential tools in modern healthcare, designed to deliver quick and accurate results for various health conditions at the point of care. These devices make diagnostics more accessible and timelier, enhancing healthcare delivery and patient outcomes. Point-of-Care Molecular Diagnostic Platform 1drop offers a comprehensive POC molecular diagnostic platform that consists of three main components: • Reagent: Specialized reagents formulated for specific tests, including molecular diagnostics. • Device: The 1POT™ Duo
POC Diagnostics Market Size 2024 to 2031.
Market Overview and Report Coverage POC, or Point of Care, Diagnostics refer to medical tests that are performed outside of a traditional laboratory setting, allowing for quicker results and immediate treatment decisions. The POC Diagnostics Market encompasses a wide range of diagnostic tests including blood glucose monitoring, pregnancy tests, infectious disease testing, and more. The future outlook of the POC Diagnostics Market is optimistic, with the market expected to grow
Point of Care (POC) Coagulation Testing Devices Market - Transforming Coagulatio …
Newark, New Castle, USA: The "Point of Care (POC) Coagulation Testing Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Point of Care (POC) Coagulation Testing Devices
POC Cardiovascular Diagnostic Market 2022 | Detailed Report
According to Market Study Report, POC Cardiovascular Diagnostic Market provides a comprehensive analysis of the POC Cardiovascular Diagnostic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5467652 The report provides a comprehensive analysis of company profiles listed below: - Abbott - Biomerieux - Danaher - F.